Annual breast cancer screening beginning at age 40 results in highest mortality reduction

Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks, according to a new study published today in Radiology, a journal of the Radiological Society of North America.

FDA+ roundup: Sen. Tillis goes after Biden administration for supporting march-in rights

Sen. Thom Tillis (R-NC) is pushing back on the Biden administration’s plans for how it hypothetically would use its controversial “march-in” authority when drug prices become

January 18, 2024

RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed – Biotech Investments

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/Miscellaneous RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed 10.08.2023 /

August 11, 2023

Chiesi Farmaceutici SpA Patent: Intraduodenal Administration of Melevodopa and Carbidopa

Share this article According to GlobalData’s company profile on Chiesi Farmaceutici, Inhalation devices was a key innovation area identified from patents. Chiesi Farmaceutici‘s grant share

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.